Avacta Group Plc (LON:AVCT)‘s stock had its “corporate” rating reiterated by stock analysts at FinnCap in a research note issued to investors on Monday.

Separately, Numis Securities Ltd restated a “buy” rating on shares of Avacta Group Plc in a report on Monday, August 1st.

Avacta Group Plc (LON:AVCT) opened at 88.05 on Monday. Avacta Group Plc has a 52 week low of GBX 83.02 and a 52 week high of GBX 140.50. The company has a 50-day moving average price of GBX 96.44 and a 200-day moving average price of GBX 100.10. The stock’s market cap is GBX 59.12 million.

Avacta Group Plc Company Profile

Avacta Group plc is a provider of research reagents, consumables and equipment to the life sciences and animal care markets. The Company provides research, development, production and delivery of instrumentation and services for the biopharmaceutical drug development and clinical diagnostics markets using biophysical technology.

Receive News & Stock Ratings for Avacta Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group Plc and related stocks with our FREE daily email newsletter.